ロード中...
Differential response to gefitinib of cells expressing normal EGFR and the mutant EGFRvIII
Epidermal growth factor receptor (EGFR) is frequently amplified and/or mutated in a number of human tumours and abnormal signalling from this receptor is believed to contribute to the malignant phenotype seen in these tumours. Gefitinib is a small molecule inhibitor that specifically binds and inhib...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
2005
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2361662/ https://ncbi.nlm.nih.gov/pubmed/16189524 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602793 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|